RIGL — Rigel Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Annual balance sheet for Rigel Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	57.3	125	58.2	56.9	77.3
Net Total Accounts Receivable
Net Total Receivables	16	15.5	40.3	30.6	41.6
Total Inventory
Prepaid Expenses
Total Current Assets	89	154	116	99.3	135
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	20.6	11.9	2.79	1.03	0.338
Net Intangible Assets
Other Long Term Assets
Total Assets	110	167	134	117	164
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	40.8	63.6	65.2	53.3	63.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	76.4	137	148	146	161
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	34	30.4	-13.6	-28.6	3.29
Total Liabilities & Shareholders' Equity	110	167	134	117	164
Total Common Shares Outstanding